Metrics as of 10/16/2026, 02:29 PM (Berlin time), refresh in progress.
Alpha Teknova Stock
Alpha Teknova, Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Stephen Gunstream
- Employees
- 158
- Market cap
- $408 M
- IPO
- 25/06/2021
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new…
Alpha Teknova stock: price history
1D
-2.4%
1W
-10.0%
1M
+10.1%
6M
+183.6%
YTD
+100.0%
1Y
+41.0%
2Y
+22.8%
5Y
-67.1%
10Y
–
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~30% stronger price swings than usual
Alpha Teknova stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
1 more assignment (Enabler/Second row) Pro-only.
Alpha Teknova, Inc. is a supplier of life sciences reagents for the pharmaceutical industry as well as research and diagnostic facilities. The company delivers essential materials such as cell culture media, prefilled media plates for cell proliferation, and chemical reagents for molecular biology processes. With a strong focus on the U.S. market, the company supports the development and production of biopharmaceutical products such as vaccines and medications. The business model is primarily oriented toward the sale of laboratory supplies and specialized clinical solutions to a diverse customer base in the life sciences sector.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Narrow
- Moat type
- Switching costs
- Capital intensity
- Low
- Customer concentration
- Low
Ask the agents about Alpha Teknova
Analyst assessment of Alpha Teknova
PRICE TARGET LOW
US$7.00
CONSENSUS
US$8.00
MEDIAN
US$8.00
PRICE TARGET HIGH
US$9.00
0
STRONG BUY
4
BUY
0
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 13/10/2026
Alpha Teknova stock metrics
P/E
-24.13
P/B
6.51
EV/EBITDA
-45.39
RETURN ON EQUITY
-5.1%
NET MARGIN
-26.0%
DEBT/EQUITY
0.44
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
20.4%
FLOAT SHARES
10,925,602
AVG. DAILY VOLUME (30D)
270,729
Insider transactions (SEC)
DEMSKI MARTHA J
DEMSKI MARTHA J
Institutional holders
Comparable stocks
Frequently asked questions about Alpha Teknova stock
What does Alpha Teknova do?
Alpha Teknova, Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Stephen Gunstream, the company employs around 158 people.
The IPO was on 25/06/2021; the stock trades on NASDAQ under the ticker TKNO.
What do analysts say about Alpha Teknova stock?
4 analysts rate the stock, the consensus is Buy (as of 13/10/2026).
The average price target is US$8.00, ranging from US$7.00 to US$9.00, with a median of US$8.00.
This is an external assessment, not a statement by Market Jury.
When does Alpha Teknova report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 30% stronger than usual.
Does Alpha Teknova pay a dividend?
No, Alpha Teknova currently does not pay a dividend.
Which stocks are comparable to Alpha Teknova?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get Alpha Teknova stock analyzed?
Clicking "Analyze stock" lets five strategies assess Alpha Teknova against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.